secwatch.observer — SEC 8-K summary
======================================

Issuer:     Keros Therapeutics, Inc. (KROS)
CIK:        0001664710
Form:       8-K
Filed at:   2026-06-01T20:02:02+00:00
Accession:  0001664710-26-000032
Event type: other_material
Sentiment:  neutral
Materiality: 0.10
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Keros CEO to present at Goldman Sachs healthcare conference June 8
------------------------------------------------------------------

- CEO Jasbir Seehra will participate in fireside chat at Goldman Sachs 47th Annual Global Healthcare Conference.
- Presentation scheduled for Monday, June 8, 2026 at 4:00 p.m. Eastern time.
- Live audio webcast available; replay accessible on Keros website for 90 days.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1664710/000166471026000032/0001664710-26-000032-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1664710/000166471026000032/kros-20260601.htm
  HTML page:      https://secwatch.observer/filing/0001664710-26-000032

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer